Diagnosis of Early LIver CAncer Through EOB-MRI Study
- Conditions
- HCC borderline lesion
- Registration Number
- JPRN-UMIN000005323
- Lead Sponsor
- Japan Liver Oncology Group
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 400
Not provided
1.Known allergy to the investigational agent or any agent given in association with this trial. 2.Patiens who have severe liver damage. 3.Asthma patients 4.Patient who has metal in the body 5.patient having the active digestive organs bleeding.It is a case with the hospitalization career within the past one month. 6.A patient of the minority. 7.Pregnant or breast-feeding patients. 8.ECOG Performance status of more than 2. 9. Any condition that could jeopardize the safety of the patient or their compliance in the study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method